Sotera Health Co cash flow statement
In fiscal 2025, Sotera Health Co's operations generated $287m of cash; it spent $138m on capital projects, leaving free cash flow of $149m.
Cash flow statement
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 149 | 121 | 282 | 278 | −148 | 224 | 287 | 292 |
| Depreciation and amortisation | 67 | 63 | 64 | 64 | 77 | 84 | 95 | 103 |
| Stock-based pay | 7 | 11 | 14 | 21 | 32 | 37 | 31 | 37 |
| Capital spending | 57 | 54 | 102 | 182 | 215 | 179 | 138 | 179 |
| Free cash flow | 92 | 67 | 179 | 96 | −363 | 45 | 149 | 113 |
| Free cash flow after stock pay | 85 | 56 | 166 | 74 | −395 | 8 | 118 | 76 |
| Dividends paid | 691 | 0 | 0 | — | — | — | — | — |
| Share buybacks | 0 | 34 | 0 | 0 | — | — | — | — |
| Shares issued | 0 | 1,156 | 0 | 0 | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 97 | 56 | 56 | 57 | 71 | 103 | 29 | 88 |
| Depreciation and amortisation | 23 | 21 | 22 | 23 | 23 | 27 | 25 | 28 |
| Stock-based pay | 10 | 8 | 7 | 8 | 8 | 8 | 14 | 7 |
| Capital spending | 36 | 66 | 20 | 31 | 36 | 51 | 46 | 46 |
| Free cash flow | 61 | −10 | 36 | 26 | 35 | 52 | −17 | 42 |
| Free cash flow after stock pay | 51 | −18 | 28 | 18 | 27 | 45 | −31 | 35 |
Compare with peers
- Bio-Techne cash flow
- Repligen Corp cash flow
- Neogenomics Inc cash flow
- Qiagen N.V. cash flow
- 10x Genomics, Inc. cash flow
Head to head: SHC vs TECHRGEN vs SHCNEO vs SHC
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies